Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment

Abstract Objective The objective of this study was to identify serum complement factor-based biomarkers indicative of clinical efficacy in patients with first-episode schizophrenia (SCZ) following treatment with aripiprazole. Methods The retrospective study cohort comprised 40 patients diagnosed wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Yin Cao, Jun Liang, Biao Dai, Feng Shan, Qingrong Xia
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s12888-024-06437-0
Tags: Add Tag
No Tags, Be the first to tag this record!